Final Agenda for 19th Annual Drug Discovery Summit

The drug discovery industry has dramatically changed over the last decade. Join over 300 high-profile delegates at Oxford Global’s 19th Annual Drug Discovery Summit, Berlin on the 7-8th June 2018 to explore the latest advancements and hear from leading industry pioneers.

 

Bringing you the latest in drug discovery innovations and strategies, discovery enabling technologies and novel drug targets for key therapeutic areas, you can expect to benefit from presentations by Chief Scientific Officers, Vice Presidents and Directors of leading organisations in the field.

 

New for 2018! We are covering a range of new areas such as new modalities, natural products and drug-target kinetics in discovery.

 

Conference highlights include:

 

• New Modalities For Treatment Of Cardiovascular & Metabolic Diseases
  Malin Lemurell, from AstraZeneca
• Identification & Drug Discovery To Illuminate Novel Patient Biology      
  Vivek K Vishnudas from Berg
• Drug Discovery Approaches To Protein Misfolding & Aggregation Diseases
  Magnus Walter from Eli Lilly
• Technology To Support Safety Optimisation For Early Drug Discovery   
  Ray Kemper from Vertex

 

The event will once again be co-located with our highly esteemed 6th Annual Discovery Chemistry & Drug Design Congress which will be covering the latest in medicinal and computational chemistry and drug design. New for 2018! We’ll be including deep dive sessions on DNA encoded libraries and hear updates on protein-protein interactions in drug discovery.

 

Key presentations include:

 

• Encoded Library Technologies In Drug Discovery  
  Christoph Dumelin from Novartis
• Molecular Availability And Accessibility - Measuring & Understanding Cellular Drug Concentrations During Lead Optimisation      
  Mike Hann from GlaxoSmithKline
• Challenges With Protein-Protein Interaction (PPI) Modulation For Immunology  
  Thorsten Thormann from Leo Pharma

 

View Agenda: http://bit.ly/2mqWK5m